Production (Stage)
Gyre Therapeutics, Inc.
GYRE
$8.07
-$0.37-4.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.97% | -20.41% | 13.20% | 13.24% | 48.37% |
| Total Receivables | 34.48% | 73.13% | -- | 54.03% | -- |
| Inventory | 59.51% | 48.03% | -- | 7.07% | -- |
| Prepaid Expenses | 355.92% | -23.14% | -- | -33.23% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 37.42% | -- | -- | -- |
| Total Current Assets | 9.13% | 13.22% | -- | 27.18% | -- |
|
|
|||||
| Total Current Assets | 9.13% | 13.22% | -- | 27.18% | -- |
| Net Property, Plant & Equipment | 5.00% | 8.08% | -- | 17.64% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 203.28% | 0.41% | -- | -93.41% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.64% | -16.93% | -- | 195.58% | -- |
| Total Assets | 6.38% | 7.61% | -- | 8.73% | -- |
|
|
|||||
| Total Accounts Payable | -63.03% | -69.58% | -- | 92.47% | -- |
| Total Accrued Expenses | -1.54% | -11.91% | -- | 10.53% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 705.00% | 239.52% | -- | 39.71% | -- |
| Total Finance Division Other Current Liabilities | -9.03% | 5.28% | -- | 42.13% | -- |
| Total Other Current Liabilities | -9.03% | 5.28% | -- | 42.13% | -- |
| Total Current Liabilities | -2.54% | -2.65% | -- | 22.15% | -- |
|
|
|||||
| Total Current Liabilities | -2.54% | -2.65% | -- | 22.15% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 345.71% | 344.72% | -- | 49,784.62% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -57.90% | -62.94% | -- | 1,128.58% | -- |
| Total Liabilities | -23.32% | -29.06% | -- | 102.45% | -- |
|
|
|||||
| Common Stock & APIC | 3.74% | 99.65% | -- | 1,481.80% | -- |
| Retained Earnings | 9.68% | 14.66% | -- | -230.83% | -- |
| Treasury Stock & Other | -43.20% | -57.97% | -- | -105.81% | -- |
| Total Common Equity | 20.27% | 500.04% | -35.27% | -38.16% | 33.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.27% | 500.04% | -35.27% | -38.16% | 33.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 12.60% | 17.82% | -- | -- | -- |
| Total Equity | 17.50% | 25.39% | 0.90% | -4.36% | 22.92% |
|
|
|||||